DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / L••• R•••• C•••••• M••••••••• I• L••
L••• R•••• C•••••• M••••••••• I• L••
LRVHealth invests with the founders changing healthcare and the organizations driving that change forward.
venture manager, reported GAV $349M across 4 vehicles
Importance
43
elevated
Active deployment
30
moderate
Emerging
0
low
Completeness
75
high
Freshness
98
high
Research priority
13
low
Identity and regulatory footprint
- Headquarters
- Boston, MAadviserinfo.sec.gov
- Office address
- ONE BOSTON PLACE, SUITE 3875, Boston, MA, 02108adviserinfo.sec.gov
- Business phone
- 617-326-3770adviserinfo.sec.gov
- Website
- l•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 23, 2026
- Private funds reported
- 4 (4 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $436Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- info@lrvhealth.comlrvhealth.compublished by the subject
- business phone
- 617-326-3770adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
46 observed deals
Stated (the firm’s website)
- Sectors
- ai, enterprise software, healthcare, consumer
- Stages
- early
- Geography
- boston
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 74%Other Health Care 15%Other Technology 11%
lead rate n/afollow-on rate n/anew logos, 12 months 46
Funds and vehicles
4 reported, 2 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| L•••••••• I•• L• | Fund | 2022 form d first sale | Active deployment | $210M Mar 26, 2024 | 46 | $200M of $200M | May 17, 2023 |
| L••••••••• L• | Fund | 2018 form d first sale | Harvest | $94.7M Mar 26, 2024 | 44 | $103M of $103M | Jun 30, 2020 |
| L••• R•••• V••••••• I••• L••• | Fund | 2014 adv first reported | Harvest | $42.6M Mar 26, 2024 | 48 | $0 of $40.0M | Jun 3, 2013 |
| L••• R•••• V••••••• I• L• | Fund | unknown | Unknown | $1.8M Mar 26, 2024 | 26 | unknown | unknown |
| L••• R•••• V•••••••• L• | Fund | unknown | Wound down | $0 Mar 31, 2017 | 22 | unknown | unknown |
| W•••••••• V•••••• F•••• L• | Fund | unknown | Wound down | $0 Mar 31, 2017 | 18 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
29 current, 0 departed
M•••••• C••••••
Board or advisoryExecutive Advisor
D•• S••••• J•••
Founder or executivePresident and Chief Executive Officer, SCAN Group and SCAN H••••• Plan
G•••• S•••••
Founder or executiveFormer Chief Executive Officer, Geisinger
R••• S••••••
Founder or executiveFormer President and Chief Executive Officer, Bon Secours Mercy H•••••
T•••• S•••
Founder or executiveFormer President and CEO, AdventH•••••
T••••• P•••••••
Founder or executivePresident and CEO Emeritus, Cedars Sinai H••••• System
W••••• C•••••••
Founder or executivePresident and Chief Executive Officer, C•••Tria
W••••• T••• M•••
Founder or executivePresident, Texas H••••• Resources
W••• C••••
General partnerCo-Founder and General Partner
J••• F•••
Managing partnerManaging Partner
K•••• J• F•••••••
Managing partnerManaging Partner
T•••• P••••
Managing partnerCo-Founder and Managing Partner
E•••• H••••••••
PartnerPartner
J••• E•••• K•••
PartnerManaging Director · since Aug 1, 2013
W•••••• R••••• C••••
PartnerManaging Director · since Jun 1, 2007
W••• D•• P••••
PartnerManaging Director · since Jun 1, 2007
A•• N••••
Platform and operationsDirector of Operations
D••• M•••••••••
Platform and operationsExecutive Vice President and Chief Financial Officer, McLaren H••••• C•••
E••• S•••••
Platform and operationsChief Financial Officer
J••• B•••••••••
Platform and operationsSVP and Chief Innovation Officer, Boston Children’s Hospital
K••••••• M••••• A•••••••
Platform and operationsPresident and Chief Operating Officer, Booz Allen Hamilton
L••••••• C••
Platform and operationsChief Strategy and Growth Officer, Allina H•••••
N••••• B••••••
Platform and operationsExecutive Assistant & Marketing Associate
R•••• B•••
Platform and operationsDirector of Marketing
T••••• B••••••
Platform and operationsFormer EVP and Chief M•••••• Officer, CVS H•••••
L•• F•••••
PrincipalFormer Director, CMS Innovation Center at Centers for Medicare & Medicaid Services
K•••• A• Y••••
Vice presidentVP, Strategic Engagement
L•••• W•••
Vice presidentExecutive Vice President and Chief Digital Officer, Sutter H•••••
Y•••• A••••••
Vice presidentSenior Associate
Investments on record
46 edges, 46 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
27 relationships from shared deals, counted for the whole firm
Ascension Ventures 2 shared · recurringH•••••y Ventures Management, LLC 1 shared · one timeOWL Ventures 1 shared · one timeWalden Catalyst 1 shared · one timeHLM Management Co., LLC 1 shared · one timeEden Road Capital, LLC 1 shared · one timeNEW Leaf Venture Partners 1 shared · one timeNCN 1 shared · one timeCultivation Capital, LLC 1 shared · one timeMMC Ventures Limited 1 shared · one timeFirst Analysis Capital Management LLC 1 shared · one timeArboretum Ventures 1 shared · one timeAperture Management LLC 1 shared · one timeIselect Fund Management, LLC 1 shared · one timeEpsilon H••••• Investors, LLC 1 shared · one timeArtis Capital Management, L.P. 1 shared · one timeDiagram Corporation 1 shared · one timeMatchstick Ventures, LLC 1 shared · one timeGreatpoint Investment Management, LLC 1 shared · one timeTAU Ventures, LLC 1 shared · one timeAnzu Partners 1 shared · one timeGenerator Ventures 1 shared · one timeAIF Management LLC 1 shared · one timeCanaan Partners 1 shared · one timeQuesta Capital Management, L.L.C. 1 shared · one timeArtis Ventures Management, L.P. 1 shared · one timeMac Venture Capital 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
30 dated events
- Sep 15, 2026S•••• H•••••: acquired by Innovaccer on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026M•••••••••: acquired by Change H•••••care on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026O••••: acquired by Waystar and H••••• H••••• on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026V•••••: acquired by O•••• on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026C•••••• H•••••: acquired by Best Buy on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026P••••••••: acquired by LabCorp on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026U••••••: acquired by H••••• Catalyst on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026D••••••• H•••••: acquired by Availity on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026H•••••••••: acquired by Humana on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026R•••••••••: acquired by McKesson on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026S•••••: acquired by OpenLoop on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026P•••••••: acquired by Qiagen on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026C•••••••: acquired by H••••• Catalyst on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026H•••••••••: acquired by Propel Media on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026L••• I••••: acquired by Intelerad on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026G•••••• N••••••: acquired by Welsh Carson on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026X••••• I•••: acquired by Samsung on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026S•••••••••: acquired by Amwell on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026R•••••••• C•••• I•••: acquired by Cureety on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Sep 15, 2026M2S: acquired by AIG on or before 2026-09-15 (no date published), per L••• R•••• C•••••• M••••••••• I• L••'s portfolio page
- Mar 24, 2023L•••••••• I•• L• first reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L•• (Venture Capital Fund), GAV $171,977,266Fund first reported on Form ADVFundsFactL•••••••• I•• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 30, 2020L••••••••• L• first reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L•• (Venture Capital Fund), GAV $14,398,200Fund first reported on Form ADVFundsFactL••••••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 2, 2018L••• R•••• V•••••••• L• no longer reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L••Fund no longer reportedFundsInferenceL••• R•••• V•••••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 2, 2018W•••••••• V•••••• F•••• L• no longer reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L••Fund no longer reportedFundsInferenceW•••••••• V•••••• F•••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 1, 2014L••• R•••• Ventures III LP first reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L•• (Venture Capital Fund), GAV $782,181Fund first reported on Form ADVFundsFactL••• R•••• V••••••• I••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 1, 2013J••• E•••• K••• joined Schedule A of L••• R•••• C•••••• M••••••••• I• L•• as Managing Director
- Mar 30, 2012L••• R•••• C•••••• M••••••••• I• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012W•••••••• V•••••• F•••• L• first reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L•• (Venture Capital Fund), GAV $6,539,474Fund first reported on Form ADVFundsFactW•••••••• V•••••• F•••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012L••• R•••• V•••••••• L• first reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L•• (Venture Capital Fund), GAV $6,862,872Fund first reported on Form ADVFundsFactL••• R•••• V•••••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012L••• R•••• V••••••• I• L• first reported on Form ADV by L••• R•••• C•••••• M••••••••• I• L•• (Venture Capital Fund), GAV $13,770,990Fund first reported on Form ADVFundsFactL••• R•••• V••••••• I• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 15, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $349M across 4 vehicles
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $347M across 3 vehicles
Evidence
63 observations from 3 sources